Meet Dijon’s Top Researchers: Pioneering Science in France
In a groundbreaking development for colorectal cancer treatment, researchers in France have demonstrated that combining a second-generation inhibitor of the heat shock protein 110 (HSP110) with PD-L1 blockade can significantly enhance antitumor immunity. The findings, published in a recent study, suggest a promising new strategy to improve the effectiveness of immune checkpoint inhibitors—particularly in cases … Read more